Latest News

SmartHeart can cut the number of required breath-holds for basic views by up to 75%, making the examination considerably more comfortable for those being scanned.

The agreement establishes a structured framework for tackling emerging and re-emerging public health threats while strengthening pandemic prevention and preparedness systems.

The self-administered nasal spray therapy bridges the gap between oral and intravenous diuretic treatments, offering patients an outpatient option for managing their condition.

Pfizer secured marketing rights to the GLP-1 compound ecnoglutide through a partnership with Hangzhou-based Sciwind Biosciences announced last month.

Sitryx stands to receive development, regulatory, and commercialization milestone payments exceeding USD 500 million, alongside tiered royalties on future sales if any drug from the partnership reaches the market.

The LEED Gold-certified facility features flexible laboratory configurations and advanced mechanical and utility systems, enabling researchers to conduct intricate scientific research.

NAFDAC released the public alert following a Notice of Concern from the WHO Prequalification service.

The site will continue operating as a subsidiary under the Syntagon name, maintaining its established brand presence in the pharmaceutical manufacturing sector.

The system combines Philips’ most advanced detector technology with AI-powered workflows and industry-leading speed, representing a significant advancement in high-acuity imaging.

The project will renovate and equip diagnostic laboratories, wastewater monitoring facilities, and environmental surveillance laboratories across six participating countries.